Lifetime Costs of Septal Reduction Therapies are Substantially Lower Compared to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy

被引：0
|
作者：
Daaboul, Yazan [1 ]
Rowin, Ethan [2 ]
Maron, Martin [2 ]
Kimmelstiel, Carey [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA USA
[2] Lahey Hosp & Med Ctr, Burlington, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 80卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-355
引用
收藏
页码：B144 / B144
页数：1
相关论文
共 50 条
  • [1] Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction
    Desai, Milind Y.
    Owens, Anjali
    Wolski, Kathy
    Geske, Jeffrey B.
    Saberi, Sara
    Wang, Andrew
    Sherrid, Mark
    Cremer, Paul C.
    Lakdawala, Neal K.
    Tower-Rader, Albree
    Fermin, David
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Zhong, Yue
    Wyrwich, Kathleen W.
    Lampl, Kathy L.
    Sehnert, Amy J.
    Nissen, Steven E.
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (11) : 1041 - 1045
  • [2] Mavacamten, an Alternative to Septal Reduction Therapy for Patients with Hypertrophic Cardiomyopathy
    Desai, Milind Y.
    Ali, Adel Hajj
    HEART INTERNATIONAL, 2023, 17 (01): : 2 - 4
  • [3] Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
    Scholtz, Smita
    Rudolph, Volker
    Reil, Jan-Christian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [4] Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy
    Cavigli, Luna
    Fumagalli, Carlo
    Maurizi, Niccolo
    Rossi, Alessandra
    Arretini, Anna
    Targetti, Mattia
    Passantino, Silvia
    Girolami, Francesca
    Tomberli, Benedetta
    Baldini, Katia
    Tomberli, Alessia
    Antoniucci, David
    Yacoub, Magdi H.
    Marchionni, Niccolo
    Stefano, Pier Luigi
    Cecchi, Franco
    Olivotto, Iacopo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 155 - 161
  • [5] Procedural Volume and Outcomes of Septal Reduction Therapies in Patients With Hypertrophic Obstructive Cardiomyopathy
    Panaich, Sidakpal S.
    Chothani, Ankit
    Badheka, Apurva O.
    JAMA CARDIOLOGY, 2017, 2 (01) : 110 - 111
  • [6] Comparison of Alcohol Septal Ablation With Mavacamten in Obstructive Hypertrophic Cardiomyopathy
    Samhan, Ashraf
    Saleh, Danish
    Kim, Ellis Y.
    Hu, Mo
    Mueller, Kayla
    Garza, Abigail
    Schormann, Elizabeth
    Bindra, Parmeen
    Cheema, Baljash
    Fullenkamp, Dominic E.
    Baldridge, Abigail S.
    Puthumana, Jyothy J.
    Flaherty, James D.
    Choudhury, Lubna
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 239 : 51 - 56
  • [7] Comparison of Alcohol Septal Ablation with Mavacamten in Obstructive Hypertrophic Cardiomyopathy
    Samhan, Ashraf
    Saleh, Danish
    Kim, Ellis
    Hu, Mo
    Mueller, Kayla
    Garza, Abigail
    Baldridge, Abigail
    Puthumana, Jyothy
    Flaherty, James
    Choudhury, Lubna
    CIRCULATION, 2024, 150
  • [8] Sex Differences in the Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
    Sreenivasan, Jayakumar
    Khan, Muhammad Shahzeb
    Kaul, Risheek
    Bandyopadhyay, Dhrubajyoti
    Hooda, Urvashi
    Aronow, Wilbert S.
    Cooper, Howard A.
    Panza, Julio A.
    Naidu, Srihari S.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (08) : 930 - 932
  • [9] Procedural Volume and Outcomes of Septal Reduction Therapies in Patients With Hypertrophic Obstructive Cardiomyopathy-Reply
    Kim, Luke K.
    Feldman, Dmitriy N.
    JAMA CARDIOLOGY, 2017, 2 (01) : 111 - 111
  • [10] Associations between procedural volume, costs, and outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy in US hospitals
    Hernandez, Ervant J. Maksabedian
    Krishnaswami, Shanthi
    Dubey, Anandkumar
    Singh, Nisha
    Jonkman, Anna G.
    Cao, Zhun
    Tyagi, Manu
    Lipkin, Craig
    Wang, Andrew
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 302 - 313
12345